STERIS
STERIS is a global leader in the infection control market, providing a comprehensive portfolio of products and services crucial for preventing and managing the spread of infections across healthcare and life science settings. The company specializes in offering advanced solutions that encompass sterilization and decontamination equipment, including state-of-the-art steam and low-temperature sterilizers, sophisticated washer-disinfectors, and automated endoscope reprocessors. Beyond equipment, STERIS delivers a wide range of essential cleaning and disinfecting chemicals, surgical support products, and sterile processing consumables. The company also extends its expertise through contract sterilization services. Through its unwavering commitment to continuous innovation and strategic growth, STERIS has substantially expanded its global footprint, cementing its reputation as a trusted, reliable partner for hospitals, pharmaceutical manufacturers, and various research institutions worldwide that require robust infection prevention and control measures.
Latest Market Research Report on Infection Control Download PDF Brochure Now
Reckitt Benckiser Group plc.
Reckitt Benckiser Group plc. is a major global force in the hygiene and infection control market, leveraging powerful consumer brands such as Dettol and Lysol. The company’s infection control offerings are extensive, covering a wide array of disinfectants and antiseptics, specialized hand hygiene products, surface cleaners, sanitizers, and general germ-protection solutions for both everyday consumer use and professional business-to-business (B2B) institutional settings. Reckitt plays a vital role in public health crises by scaling up the production and supply of its disinfectant and sanitization products to actively help reduce the spread of infections, exemplified during the COVID-19 pandemic. Its strategic focus on core hygiene and health products, alongside continuous innovation in germ-protection formulations, drives its market presence. By expanding its B2B channels to distribute institutional-grade solutions like Lysol and Dettol to various organizations, Reckitt Benckiser reinforces its critical position in the global infection control landscape.
Medline Industries, LP.
Medline Industries, LP. is a prominent and comprehensive player in the infection control market, offering an extensive range of essential products that advance infection control practices across the healthcare continuum, including long-term care facilities. The company’s product line includes crucial items such as masks, various surgical gloves, sterilization wraps, and gowns for surgeons, all designed with a focus on quality and security. Medline is committed to supporting healthcare systems in implementing effective infection control protocols, often through programs that provide targeted education, training, and viable solutions to address identified gaps, such as in hand hygiene and PPE compliance. The company collaborates with providers to customize infection prevention programs, reinforcing best practices and clinical standardization. By focusing on essential products and providing the educational support needed to improve compliance and staff training, Medline acts as a key enabler for enhanced patient safety and efficient operations in healthcare facilities.
Cardinal Health, Inc.
Cardinal Health, Inc. stands as one of the leading global providers of infection prevention devices, offering a broad and innovative portfolio designed to enhance patient safety and operational efficiency in healthcare settings. The company’s comprehensive product range includes critical items like Personal Protective Equipment (PPE), surgical drapes, advanced sterilization wraps, and various facial protection products. Cardinal Health’s focus is on delivering solutions that support comprehensive infection prevention strategies, making them a crucial resource for hospitals and clinics worldwide. By providing a wide array of high-quality products, the company addresses multiple facets of infection control, from preparing for surgical procedures to protecting healthcare workers and patients during daily care routines. Their strong market presence is built on the foundation of supplying essential, reliable, and innovative products that contribute directly to better patient outcomes and more effective infection management practices.
3M Company
3M Company is renowned as an innovation leader in the infection control market, leveraging its science-based solutions to address critical healthcare challenges. The company’s offerings are specifically designed to enhance patient and healthcare worker safety, covering essential areas such as sterilization, advanced respiratory protection, and cross-contamination control. 3M provides state-of-the-art products and is dedicated to supporting facilities in dealing with healthcare-acquired infections (HAIs) through education and training. Historically, 3M’s healthcare division was a significant part of the infection control market, introducing new lines of surgical drapes with advanced infection prevention technology. Although a portion of its healthcare business spun off into Solventum, the 3M brand remains influential in providing specialized, innovative tools and systems—including those for respiratory protection—that are integral to maintaining high hygiene standards and reducing infection risk in clinical practices globally.
Becton, Dickinson and Company (BD)
Becton, Dickinson and Company, or BD, is a key market player in infection control, distinguished by its diverse portfolio of products aimed at enhancing patient safety and quality of care. BD provides solutions that are vital for preventing infections, particularly in surgical settings. Their product offerings include specialized skin antiseptics, high-efficacy surgical hand scrubs, pre-surgical hair removal systems, and antimicrobial irrigation systems designed for wound care to actively prevent post-operative infections. BD’s commitment extends to supporting best clinical practices around the world by providing innovative tools that improve surgical performance and patient outcomes. The company’s focus on areas like pre-surgical preparation and wound infection prevention solidifies its position as an important contributor to global efforts to reduce healthcare-acquired infections and promote a safer healthcare environment.
Paul Hartmann AG (HARTMANN Group)
The HARTMANN Group, with roots dating back to 1818, is a leading company in the infection prevention devices market, committed to making healthcare more efficient while prioritizing patients and staff. The company offers a specialized range of products, including their well-known Sterillium® disinfectants, high-quality surgical gloves, and CombiSet® kits for various procedures. HARTMANN drives the advancement of hygiene standards and clinical practices globally through innovative solutions and initiatives, such as its “Mission: Infection Prevention.” Their commitment is to offer products that enable healthcare professionals to maintain stringent hygiene standards and clinical safety. By focusing on critical areas like hand hygiene and surgical set customization, the HARTMANN Group reinforces its reputation as a key partner in the global effort to prevent and control infections across healthcare environments, providing the necessary tools to enhance safety and efficiency.
Fortive (via Advanced Sterilization Products)
Fortive has significantly bolstered its position in the infection control market through the strategic acquisition of Advanced Sterilization Products (ASP), which is a recognized leader in sterilization and disinfection technologies. This acquisition has been transformative, expanding Fortive’s portfolio of infection prevention solutions and strengthening its foothold in critical segments like hospital reprocessing and sterilization. The company’s focus is on delivering advanced technologies that ensure medical instruments are properly sterilized and disinfected, a foundational element of infection control. Through ASP’s established customer base, Fortive enhances its global market reach, providing sophisticated solutions that improve compliance and safety. By integrating ASP’s expertise in sterilization into its portfolio, Fortive plays a crucial role in enabling hospitals to reduce the risk of surgical site infections and other healthcare-acquired infections, thereby supporting a safer patient environment worldwide.
Sotera Health
Sotera Health is a major player in the infection control market, providing a comprehensive range of solutions primarily centered on ensuring the safety of medical devices and products through sterilization services. The company has a strong focus on enhancing public health by reducing the risk of infection and disease transmission through its sterilization and lab testing services. Sotera Health is committed to maintaining the integrity and efficacy of healthcare products. Its services are crucial for various segments of the medical industry, allowing manufacturers to bring safe, sterilized devices to market. By expanding its facility footprint and continuously investing in strong R&D, Sotera Health solidifies its position as an essential provider of outsourced sterilization and safety solutions. This specialized focus on product safety and sterilization is a vital component of the overall infection control ecosystem, enabling healthcare facilities to rely on the safety of the tools they use for patient care.
Solventum
Solventum, a major new entity in the infection control market, was established through the spin-off of 3M’s healthcare division. This strategic move was designed to enable the new company to sharpen its focus, drive greater operational agility, and pursue targeted growth opportunities specifically within infection prevention and control. Solventum inherits a strong legacy in providing infection prevention solutions, including those related to surgical site infection prevention and hospital reprocessing. By operating as an independent entity, the company can prioritize innovation and market expansion for its infection control portfolio without the structural constraints of its former parent company. This newfound focus allows Solventum to accelerate the development of next-generation infection control products and solutions, enhancing its competitiveness and ensuring a continued impact on reducing healthcare-acquired infections and promoting better patient safety globally.
Latest Market Research Report on Infection Control Download PDF Brochure Now